MTM Investment Management LLC Takes $130,000 Position in CME Group Inc. $CME

MTM Investment Management LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 472 shares of the financial services provider’s stock, valued at approximately $130,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CME. Webster Bank N. A. grew its holdings in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC raised its holdings in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the period. Ransom Advisory Ltd acquired a new stake in CME Group during the first quarter worth approximately $31,000. Trifecta Capital Advisors LLC boosted its holdings in shares of CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 42 shares during the period. Finally, Westside Investment Management Inc. grew its position in shares of CME Group by 105.0% in the second quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 63 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director William R. Shepard purchased 262 shares of the stock in a transaction dated Thursday, September 25th. The shares were bought at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have sold 14,043 shares of company stock valued at $3,791,486. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.5%

Shares of CME Group stock opened at $285.04 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $222.56 and a 12-month high of $290.79. The company has a market capitalization of $102.79 billion, a price-to-earnings ratio of 27.62, a PEG ratio of 4.41 and a beta of 0.38. The firm’s 50-day moving average price is $267.33 and its two-hundred day moving average price is $272.82.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.68 EPS. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CME. Piper Sandler increased their price objective on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday. JPMorgan Chase & Co. raised their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research note on Monday, October 13th. UBS Group cut their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. Finally, The Goldman Sachs Group raised their target price on shares of CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a report on Thursday, October 23rd. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $287.65.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.